Abciximab
Choline magnesium trisalicylate may increase the anticoagulant activities of Abciximab.
Acebutolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Acebutolol.
Aceclofenac
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Aceclofenac.
Advertisement
Acemetacin
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Acemetacin.
Acenocoumarol
Choline magnesium trisalicylate may increase the anticoagulant activities of Acenocoumarol.
Acetaminophen
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Acetaminophen.
Advertisement
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Choline magnesium trisalicylate.
Alclometasone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Alclometasone.
Aldosterone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Aldosterone.
Advertisement
Alendronate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Alendronic acid.
Alendronic acid
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Alendronic acid.
Aliskiren
Choline magnesium trisalicylate may decrease the antihypertensive activities of Aliskiren.
Alminoprofen
The risk or severity of adverse effects can be increased when Alminoprofen is combined with Choline magnesium trisalicylate.
Alprenolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Alprenolol.
Alprostadil
The therapeutic efficacy of Alprostadil can be decreased when used in combination with Choline magnesium trisalicylate.
Amcinonide
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Amcinonide.
Amikacin
Choline magnesium trisalicylate may decrease the excretion rate of Amikacin which could result in a higher serum level.
Amiloride
Choline magnesium trisalicylate may decrease the antihypertensive activities of Amiloride.
Aminosalicylic Acid
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Aminosalicylic Acid.
Amiodarone
Choline magnesium trisalicylate may decrease the antihypertensive activities of Amiodarone.
Ancrod
Choline magnesium trisalicylate may increase the anticoagulant activities of Ancrod.
Androstenedione
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Androstenedione.
Anhydrous Tacrolimus
Choline magnesium trisalicylate may increase the nephrotoxic activities of Tacrolimus.
Antipyrine
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Antipyrine.
Antithrombin III
Choline magnesium trisalicylate may increase the anticoagulant activities of Antithrombin III human.
Antithrombin III, Human
Choline magnesium trisalicylate may increase the anticoagulant activities of Antithrombin III human.
Apazone
The risk or severity of adverse effects can be increased when Azapropazone is combined with Choline magnesium trisalicylate.
Apixaban
Choline magnesium trisalicylate may increase the anticoagulant activities of Apixaban.
Apremilast
The risk or severity of adverse effects can be increased when Apremilast is combined with Choline magnesium trisalicylate.
Arbekacin
Choline magnesium trisalicylate may decrease the excretion rate of Arbekacin which could result in a higher serum level.
Ardeparin
Choline magnesium trisalicylate may increase the anticoagulant activities of Ardeparin.
Argatroban
Choline magnesium trisalicylate may increase the anticoagulant activities of Argatroban.
Argatroban Anhydrous
Choline magnesium trisalicylate may increase the anticoagulant activities of Argatroban.
Asenapine
Choline magnesium trisalicylate may decrease the antihypertensive activities of Asenapine.
Asian ginseng extract
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Ginseng.
Atenolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Atenolol.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Choline magnesium trisalicylate.
azficel-T
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Azficel-T.
Azilsartan
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Choline magnesium trisalicylate.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Choline magnesium trisalicylate.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Choline magnesium trisalicylate.
Azosemide
The therapeutic efficacy of Azosemide can be decreased when used in combination with Choline magnesium trisalicylate.
Balsalazide
The risk or severity of adverse effects can be increased when Balsalazide is combined with Choline magnesium trisalicylate.
Bazedoxifene
Choline magnesium trisalicylate may increase the thrombogenic activities of Bazedoxifene.
Becaplermin
Choline magnesium trisalicylate may increase the anticoagulant activities of Becaplermin.
Beclomethasone Dipropionate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Beclomethasone dipropionate.
Benazepril
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Benazepril.
Bendroflumethiazide
The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Choline magnesium trisalicylate.
Benzthiazide
The therapeutic efficacy of Benzthiazide can be decreased when used in combination with Choline magnesium trisalicylate.
Benzydamine
The risk or severity of adverse effects can be increased when Benzydamine is combined with Choline magnesium trisalicylate.
Betamethasone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Betamethasone.
Betaxolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Betaxolol.
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Choline magnesium trisalicylate.
Bimatoprost
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Choline magnesium trisalicylate.
Bisoprolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Bisoprolol.
Bivalirudin
Choline magnesium trisalicylate may increase the anticoagulant activities of Bivalirudin.
Bopindolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Bopindolol.
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Choline magnesium trisalicylate.
Budesonide
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Budesonide.
Bufexamac
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Bufexamac.
Bumetanide
The therapeutic efficacy of Bumetanide can be decreased when used in combination with Choline magnesium trisalicylate.
Bupranolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Bupranolol.
Candesartan
The risk or severity of adverse effects can be increased when Candesartan is combined with Choline magnesium trisalicylate.
Candesartan Cilexetil
The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Choline magnesium trisalicylate.
Capsaicin
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Capsaicin.
Captopril
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Captopril.
Carboprost
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Choline magnesium trisalicylate.
Carboprost Tromethamine
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Choline magnesium trisalicylate.
Carprofen
The risk or severity of adverse effects can be increased when Carprofen is combined with Choline magnesium trisalicylate.
Carteolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Carteolol.
Carvedilol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Carvedilol.
Celecoxib
The risk or severity of adverse effects can be increased when Celecoxib is combined with Choline magnesium trisalicylate.
Celiprolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Celiprolol.
Certoparin
Choline magnesium trisalicylate may increase the anticoagulant activities of Certoparin.
Chloroquine
The risk or severity of adverse effects can be increased when Chloroquine is combined with Choline magnesium trisalicylate.
Chlorothiazide
The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Choline magnesium trisalicylate.
Chlorotrianisene
Choline magnesium trisalicylate may increase the thrombogenic activities of Chlorotrianisene.
Chlorphenesin
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Chlorphenesin.
Chlorthalidone
The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Choline magnesium trisalicylate.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Choline magnesium trisalicylate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ciclesonide
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Ciclesonide.
Cilazapril
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Cilazapril.
Cinoxacin
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Cinoxacin.
Ciprofloxacin
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Ciprofloxacin.
Cisplatin
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Cisplatin.
Citalopram
Citalopram may increase the antiplatelet activities of Choline magnesium trisalicylate.
Citric Acid
Choline magnesium trisalicylate may increase the anticoagulant activities of Citric Acid.
Citric Acid, Anhydrous
Choline magnesium trisalicylate may increase the anticoagulant activities of Citric Acid.
Clobetasol
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Clobetasol.
Clobetasol Propionate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Clobetasol propionate.
Clobetasone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Clobetasone.
Clocortolone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Clocortolone.
Clodronic Acid
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Clodronic Acid.
Clonixin
The risk or severity of adverse effects can be increased when Clonixin is combined with Choline magnesium trisalicylate.
Colesevelam
Colesevelam can cause a decrease in the absorption of Choline magnesium trisalicylate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Choline magnesium trisalicylate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cortisone Acetate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Cortisone acetate.
Curcumin
The risk or severity of adverse effects can be increased when Curcumin is combined with Choline magnesium trisalicylate.
Cyclopenthiazide
The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Choline magnesium trisalicylate.
Cyclosporine
Choline magnesium trisalicylate may increase the nephrotoxic activities of Cyclosporine.
Dabigatran Etexilate
Choline magnesium trisalicylate may increase the anticoagulant activities of Dabigatran etexilate.
Dalteparin
Choline magnesium trisalicylate may increase the anticoagulant activities of Dalteparin.
Danaparoid
Choline magnesium trisalicylate may increase the anticoagulant activities of Danaparoid.
Deferasirox
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Deferasirox.
Deflazacort
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Deflazacort.
Desipramine
Choline magnesium trisalicylate may decrease the antihypertensive activities of Desipramine.
Desirudin
Choline magnesium trisalicylate may increase the anticoagulant activities of Desirudin.
Desmopressin
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Desmopressin.
Desonide
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Desonide.
Desoximetasone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Desoximetasone.
Desoxycorticosterone acetate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Desoxycorticosterone acetate.
Desoxycorticosterone Pivalate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Desoxycorticosterone Pivalate.
Desvenlafaxine
Desvenlafaxine may increase the antiplatelet activities of Choline magnesium trisalicylate.
Dexamethasone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Dexamethasone.
Dexketoprofen
The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Choline magnesium trisalicylate.
Dextran
Choline magnesium trisalicylate may increase the anticoagulant activities of Dextran.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Choline magnesium trisalicylate.
Dicumarol
Choline magnesium trisalicylate may increase the anticoagulant activities of Dicoumarol.
Dienestrol
Choline magnesium trisalicylate may increase the thrombogenic activities of Dienestrol.
Diethylstilbestrol
Choline magnesium trisalicylate may increase the thrombogenic activities of Diethylstilbestrol.
Diflorasone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Diflorasone.
Diflucortolone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Difluocortolone.
Diflunisal
The risk or severity of adverse effects can be increased when Diflunisal is combined with Choline magnesium trisalicylate.
Difluprednate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Difluprednate.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Choline magnesium trisalicylate.
Dihydrostreptomycin
Choline magnesium trisalicylate may decrease the excretion rate of Dihydrostreptomycin which could result in a higher serum level.
Dinoprost
The therapeutic efficacy of Dinoprost can be decreased when used in combination with Choline magnesium trisalicylate.
Dinoprost Tromethamine
The therapeutic efficacy of Dinoprost Tromethamine can be decreased when used in combination with Choline magnesium trisalicylate.
Dinoprostone
The therapeutic efficacy of Dinoprostone can be decreased when used in combination with Choline magnesium trisalicylate.
Dipyrone
The risk or severity of adverse effects can be increased when Metamizole is combined with Choline magnesium trisalicylate.
Drospirenone
Choline magnesium trisalicylate may increase the hyperkalemic activities of Drospirenone.
Droxicam
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Droxicam.
Duloxetine
Duloxetine may increase the antiplatelet activities of Choline magnesium trisalicylate.
Edetic Acid
Choline magnesium trisalicylate may increase the anticoagulant activities of Edetic Acid.
Edoxaban
Choline magnesium trisalicylate may increase the anticoagulant activities of Edoxaban.
Eicosapentaenoic Acid
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Icosapent.
Enalapril
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Enalapril.
Enalaprilat
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Enalaprilat.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Enalaprilat.
Enoxacin
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Enoxacin.
Enoxaparin
Choline magnesium trisalicylate may increase the anticoagulant activities of Enoxaparin.
Enoxaparin sodium
Choline magnesium trisalicylate may increase the anticoagulant activities of Enoxaparin.
Eplerenone
Choline magnesium trisalicylate may decrease the antihypertensive activities of Eplerenone.
Epoprostenol
The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Choline magnesium trisalicylate.
Eprosartan
The risk or severity of adverse effects can be increased when Eprosartan is combined with Choline magnesium trisalicylate.
Equol, (-)-
Choline magnesium trisalicylate may increase the thrombogenic activities of Equol.
Escitalopram
Escitalopram may increase the antiplatelet activities of Choline magnesium trisalicylate.
Esmolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Esmolol.
Estradiol
Choline magnesium trisalicylate may increase the thrombogenic activities of Estradiol.
Estradiol acetate
Choline magnesium trisalicylate may increase the thrombogenic activities of Estradiol acetate.
Estradiol Cypionate
Choline magnesium trisalicylate may increase the thrombogenic activities of Estradiol cypionate.
Estradiol Valerate
Choline magnesium trisalicylate may increase the thrombogenic activities of Estradiol valerate.
Estriol
Choline magnesium trisalicylate may increase the thrombogenic activities of Estriol.
Estrogens, Conjugated (USP)
Choline magnesium trisalicylate may increase the thrombogenic activities of Conjugated estrogens.
Estrogens, Esterified (USP)
Choline magnesium trisalicylate may increase the thrombogenic activities of Estrogens, esterified.
Estrone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Estrone.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Choline magnesium trisalicylate.
Ethacrynate
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Choline magnesium trisalicylate.
Ethacrynic Acid
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Choline magnesium trisalicylate.
Ethinyl Estradiol
Choline magnesium trisalicylate may increase the thrombogenic activities of Ethinyl Estradiol.
Ethylenediaminetetraacetate
Choline magnesium trisalicylate may increase the anticoagulant activities of Edetic Acid.
Etidronate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Etidronic acid.
Etidronic Acid
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Etidronic acid.
Etodolac
The risk or severity of adverse effects can be increased when Etodolac is combined with Choline magnesium trisalicylate.
Etofenamate
The risk or severity of adverse effects can be increased when Etofenamate is combined with Choline magnesium trisalicylate.
Etoricoxib
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Etoricoxib.
Evening primrose oil
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Choline magnesium trisalicylate.
Felbinac
The risk or severity of adverse effects can be increased when Felbinac is combined with Choline magnesium trisalicylate.
Fenbufen
The risk or severity of adverse effects can be increased when Fenbufen is combined with Choline magnesium trisalicylate.
Fenoprofen
The risk or severity of adverse effects can be increased when Fenoprofen is combined with Choline magnesium trisalicylate.
Ferulic Acid
The risk or severity of adverse effects can be increased when Ferulic acid is combined with Choline magnesium trisalicylate.
Fish Oils
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Fish oil.
Fleroxacin
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Fleroxacin.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Choline magnesium trisalicylate.
Fludrocortisone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Fludrocortisone.
Fluindione
Choline magnesium trisalicylate may increase the anticoagulant activities of Fluindione.
Flumequine
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Flumequine.
Flumethasone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Flumethasone.
Flunisolide
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Flunisolide.
Flunisolide Anhydrous (obsolete)
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Flunisolide.
Fluocinolone Acetonide
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Fluocinolone Acetonide.
Fluocinonide
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Fluocinonide.
Fluocortolone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Fluocortolone.
Fluorometholone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Fluorometholone.
Fluoxetine
Fluoxetine may increase the antiplatelet activities of Choline magnesium trisalicylate.
FLUPREDNIDENE
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Fluprednidene.
Fluprednisolone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Fluprednisolone.
Flurandrenolide
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Flurandrenolide.
Flurbiprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Choline magnesium trisalicylate.
Fluticasone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Fluticasone.
Fluticasone Furoate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Fluticasone furoate.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Fluticasone propionate.
Fluvoxamine
Fluvoxamine may increase the antiplatelet activities of Choline magnesium trisalicylate.
Folate
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Choline magnesium trisalicylate.
Folic Acid
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Choline magnesium trisalicylate.
Fondaparinux sodium
Choline magnesium trisalicylate may increase the anticoagulant activities of Fondaparinux sodium.
Formestane
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Formestane.
Fosinopril
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Fosinopril.
Framycetin
Choline magnesium trisalicylate may decrease the excretion rate of Framycetin which could result in a higher serum level.
Furosemide
The therapeutic efficacy of Furosemide can be decreased when used in combination with Choline magnesium trisalicylate.
Gatifloxacin
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Gatifloxacin.
Gatifloxacin Anhydrous
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Gatifloxacin.
Gemeprost
The therapeutic efficacy of Gemeprost can be decreased when used in combination with Choline magnesium trisalicylate.
Gemifloxacin
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Gemifloxacin.
Gemifloxacin Mesylate
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Gemifloxacin.
Genistein
Choline magnesium trisalicylate may increase the thrombogenic activities of Genistein.
Gentamicin
Choline magnesium trisalicylate may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Ginseng Preparation
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Ginseng.
Grepafloxacin
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Grepafloxacin.
Halcinonide
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Halcinonide.
Halobetasol
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Ulobetasol.
Haloperidol
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Haloperidol.
Heparin
Choline magnesium trisalicylate may increase the anticoagulant activities of Heparin.
Hydralazine
Choline magnesium trisalicylate may decrease the antihypertensive activities of Hydralazine.
Hydrochlorothiazide
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Choline magnesium trisalicylate.
Hydrocortisone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Choline magnesium trisalicylate.
Ibandronate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Ibandronate.
Ibandronic Acid
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Ibandronate.
Ibuprofen
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Choline magnesium trisalicylate.
Icatibant
The risk or severity of adverse effects can be increased when Icatibant is combined with Choline magnesium trisalicylate.
Iloprost
The therapeutic efficacy of Iloprost can be decreased when used in combination with Choline magnesium trisalicylate.
Imidapril
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Imidapril.
Indapamide
The therapeutic efficacy of Indapamide can be decreased when used in combination with Choline magnesium trisalicylate.
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Choline magnesium trisalicylate.
Indomethacin
The risk or severity of adverse effects can be increased when Indomethacin is combined with Choline magnesium trisalicylate.
Irbesartan
The risk or severity of adverse effects can be increased when Irbesartan is combined with Choline magnesium trisalicylate.
Kanamycin
Choline magnesium trisalicylate may decrease the excretion rate of Kanamycin which could result in a higher serum level.
kanamycin A
Choline magnesium trisalicylate may decrease the excretion rate of Kanamycin which could result in a higher serum level.
Kebuzone
The risk or severity of adverse effects can be increased when Kebuzone is combined with Choline magnesium trisalicylate.
Ketoprofen
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Choline magnesium trisalicylate.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Choline magnesium trisalicylate.
Korean ginseng preparation
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Ginseng.
KOREAN GINSENG ROOT
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Ginseng.
Korean Ginseng Root Extract
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Ginseng.
Labetalol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Labetalol.
Latanoprost
The therapeutic efficacy of Latanoprost can be decreased when used in combination with Choline magnesium trisalicylate.
Latanoprostene Bunod
The therapeutic efficacy of Latanoprostene Bunod can be decreased when used in combination with Choline magnesium trisalicylate.
Leflunomide
The risk or severity of adverse effects can be increased when Leflunomide is combined with Choline magnesium trisalicylate.
Lepirudin
Choline magnesium trisalicylate may increase the anticoagulant activities of Lepirudin.
Levobetaxolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Levobetaxolol.
Levobunolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Levobunolol.
Levofloxacin
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Levofloxacin.
Levofloxacin Anhydrous
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Levofloxacin.
Levomilnacipran
Levomilnacipran may increase the antiplatelet activities of Choline magnesium trisalicylate.
Limonene, (+)-
The risk or severity of adverse effects can be increased when (4R)-limonene is combined with Choline magnesium trisalicylate.
Lisinopril
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Lisinopril.
Lisinopril Anhydrous
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Lisinopril.
Lithium
The serum concentration of Lithium can be increased when it is combined with Choline magnesium trisalicylate.
Lithium Cation
The serum concentration of Lithium can be increased when it is combined with Choline magnesium trisalicylate.
Lomefloxacin
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Lomefloxacin.
Lornoxicam
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Lornoxicam.
Losartan
The risk or severity of adverse effects can be increased when Losartan is combined with Choline magnesium trisalicylate.
Loteprednol
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Loteprednol.
Loxoprofen
The risk or severity of adverse effects can be increased when Loxoprofen is combined with Choline magnesium trisalicylate.
Lubiprostone
The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Choline magnesium trisalicylate.
Magnesium Salicylate
The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Choline magnesium trisalicylate.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Choline magnesium trisalicylate.
Meclofenamate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Choline magnesium trisalicylate.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Choline magnesium trisalicylate.
Medronate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Technetium Tc-99m medronate.
Medrysone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Medrysone.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Choline magnesium trisalicylate.
Meloxicam
The risk or severity of adverse effects can be increased when Meloxicam is combined with Choline magnesium trisalicylate.
Mepindolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Mepindolol.
Mesalamine
The risk or severity of adverse effects can be increased when Mesalazine is combined with Choline magnesium trisalicylate.
Mestranol
Choline magnesium trisalicylate may increase the thrombogenic activities of Mestranol.
Methotrexate
The serum concentration of Methotrexate can be increased when it is combined with Choline magnesium trisalicylate.
Methyclothiazide
The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Choline magnesium trisalicylate.
Methylprednisolone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Methylprednisolone.
Metipranolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Metipranolol.
Metolazone
The therapeutic efficacy of Metolazone can be decreased when used in combination with Choline magnesium trisalicylate.
Metoprolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Metoprolol.
Milnacipran
Milnacipran may increase the antiplatelet activities of Choline magnesium trisalicylate.
Misoprostol
The therapeutic efficacy of Misoprostol can be decreased when used in combination with Choline magnesium trisalicylate.
Moexipril
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Moexipril.
Mometasone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Mometasone.
Morniflumate
The risk or severity of adverse effects can be increased when Morniflumate is combined with Choline magnesium trisalicylate.
Moxifloxacin
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Moxifloxacin.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Choline magnesium trisalicylate.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Choline magnesium trisalicylate.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Choline magnesium trisalicylate.
Nabumetone
The risk or severity of adverse effects can be increased when Nabumetone is combined with Choline magnesium trisalicylate.
Nadolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Nadolol.
Nadroparin
Choline magnesium trisalicylate may increase the anticoagulant activities of Nadroparin.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Choline magnesium trisalicylate.
Nalidixic Acid
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Nalidixic Acid.
Naproxen
The risk or severity of adverse effects can be increased when Naproxen is combined with Choline magnesium trisalicylate.
Nebivolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Nebivolol.
Nefazodone
Nefazodone may increase the antiplatelet activities of Choline magnesium trisalicylate.
Neomycin
Choline magnesium trisalicylate may decrease the excretion rate of Neomycin which could result in a higher serum level.
Nepafenac
The risk or severity of adverse effects can be increased when Nepafenac is combined with Choline magnesium trisalicylate.
Netilmicin
Choline magnesium trisalicylate may decrease the excretion rate of Netilmicin which could result in a higher serum level.
Niflumic Acid
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Niflumic Acid.
Nimesulide
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Nimesulide.
Norfloxacin
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Norfloxacin.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Choline magnesium trisalicylate.
Ofloxacin
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Ofloxacin.
Olmesartan
The risk or severity of adverse effects can be increased when Olmesartan is combined with Choline magnesium trisalicylate.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Choline magnesium trisalicylate.
Olsalazine
The risk or severity of adverse effects can be increased when Olsalazine is combined with Choline magnesium trisalicylate.
Omacetaxine Mepesuccinate
The risk or severity of bleeding can be increased when Choline magnesium trisalicylate is combined with Omacetaxine mepesuccinate.
Oxaprozin
The risk or severity of adverse effects can be increased when Oxaprozin is combined with Choline magnesium trisalicylate.
Oxprenolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Oxprenolol.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Choline magnesium trisalicylate.
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Choline magnesium trisalicylate.
Pamidronate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Pamidronate.
Pamidronic Acid
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Pamidronate.
Paramethasone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Paramethasone.
Parecoxib
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Parecoxib.
Paromomycin
Choline magnesium trisalicylate may decrease the excretion rate of Paromomycin which could result in a higher serum level.
Paroxetine
Paroxetine may increase the antiplatelet activities of Choline magnesium trisalicylate.
Parthenolide
The risk or severity of adverse effects can be increased when Parthenolide is combined with Choline magnesium trisalicylate.
Pefloxacin
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Pefloxacin.
Penbutolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Penbutolol.
Pentaerythritol Tetranitrate
Choline magnesium trisalicylate may increase the anticoagulant activities of Pentaerythritol Tetranitrate.
Pentosan Polysulfate
Choline magnesium trisalicylate may increase the anticoagulant activities of Pentosan Polysulfate.
Perindopril
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Perindopril.
Phenindione
Choline magnesium trisalicylate may increase the anticoagulant activities of Phenindione.
Phenprocoumon
Choline magnesium trisalicylate may increase the anticoagulant activities of Phenprocoumon.
Phenylbutazone
The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Choline magnesium trisalicylate.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Choline magnesium trisalicylate.
Pindolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Pindolol.
Piretanide
The therapeutic efficacy of Piretanide can be decreased when used in combination with Choline magnesium trisalicylate.
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Choline magnesium trisalicylate.
Piroxicam
The risk or severity of adverse effects can be increased when Piroxicam is combined with Choline magnesium trisalicylate.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Piroxicam is combined with Choline magnesium trisalicylate.
Plazomicin
Choline magnesium trisalicylate may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Polyestradiol Phosphate
Choline magnesium trisalicylate may increase the thrombogenic activities of Polyestradiol phosphate.
Polythiazide
The therapeutic efficacy of Polythiazide can be decreased when used in combination with Choline magnesium trisalicylate.
Pomalidomide
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Pomalidomide.
Potassium Citrate
Choline magnesium trisalicylate may increase the anticoagulant activities of Potassium Citrate.
Practolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Practolol.
Pralatrexate
The serum concentration of Pralatrexate can be increased when it is combined with Choline magnesium trisalicylate.
Prasterone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Prasterone.
Prednicarbate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Prednicarbate.
Prednisolone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Prednisolone.
Prednisone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Prednisone.
Pregnenolone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Pregnenolone.
Probenecid
The serum concentration of Choline magnesium trisalicylate can be increased when it is combined with Probenecid.
Promestriene
Choline magnesium trisalicylate may increase the thrombogenic activities of Promestriene.
Propafenone
Choline magnesium trisalicylate may decrease the antihypertensive activities of Propafenone.
Propranolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Propranolol.
protein C, human
Choline magnesium trisalicylate may increase the anticoagulant activities of Protein C.
protein S, human
Choline magnesium trisalicylate may increase the anticoagulant activities of Protein S human.
Protocatechualdehyde
Choline magnesium trisalicylate may increase the anticoagulant activities of Protocatechualdehyde.
Quinapril
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Quinapril.
Quinestrol
Choline magnesium trisalicylate may increase the thrombogenic activities of Quinestrol.
Quinethazone
The therapeutic efficacy of Quinethazone can be decreased when used in combination with Choline magnesium trisalicylate.
Ramipril
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Ramipril.
Rescinnamine
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Rescinnamine.
Resveratrol
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Resveratrol.
Reviparin
Choline magnesium trisalicylate may increase the anticoagulant activities of Reviparin.
Reviparin sodium
Choline magnesium trisalicylate may increase the anticoagulant activities of Reviparin.
Rimexolone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Rimexolone.
Risedronate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Risedronate.
Risedronic Acid
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Risedronate.
Rivaroxaban
Choline magnesium trisalicylate may increase the anticoagulant activities of Rivaroxaban.
Rofecoxib
The risk or severity of adverse effects can be increased when Rofecoxib is combined with Choline magnesium trisalicylate.
Rosoxacin
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Rosoxacin.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Choline magnesium trisalicylate.
Salicylamide
The risk or severity of adverse effects can be increased when Salicylamide is combined with Choline magnesium trisalicylate.
Salicylic Acid
The risk or severity of adverse effects can be increased when Salicylic acid is combined with Choline magnesium trisalicylate.
Salsalate
The risk or severity of adverse effects can be increased when Salsalate is combined with Choline magnesium trisalicylate.
Saralasin
The risk or severity of adverse effects can be increased when Saralasin is combined with Choline magnesium trisalicylate.
Sarilumab
Sarilumab may increase the immunosuppressive activities of Choline magnesium trisalicylate.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Serrapeptase is combined with Choline magnesium trisalicylate.
Sertraline
Sertraline may increase the antiplatelet activities of Choline magnesium trisalicylate.
Sisomicin
Choline magnesium trisalicylate may decrease the excretion rate of Sisomicin which could result in a higher serum level.
Sodium Citrate
Choline magnesium trisalicylate may increase the anticoagulant activities of Sodium Citrate.
Sodium Phosphate
Sodium phosphate may increase the nephrotoxic activities of Choline magnesium trisalicylate.
Sodium Phosphate, Monobasic
Sodium phosphate may increase the nephrotoxic activities of Choline magnesium trisalicylate.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Sodium phosphate may increase the nephrotoxic activities of Choline magnesium trisalicylate.
Sotalol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Sotalol.
Sparfloxacin
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Sparfloxacin.
Spirapril
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Spirapril.
Spironolactone
Choline magnesium trisalicylate may decrease the antihypertensive activities of Spironolactone.
Streptomycin
Choline magnesium trisalicylate may decrease the excretion rate of Streptomycin which could result in a higher serum level.
Sulfasalazine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Choline magnesium trisalicylate.
Sulindac
The risk or severity of adverse effects can be increased when Sulindac is combined with Choline magnesium trisalicylate.
Suprofen
The risk or severity of adverse effects can be increased when Suprofen is combined with Choline magnesium trisalicylate.
synthetic conjugated estrogens, A
Choline magnesium trisalicylate may increase the thrombogenic activities of Synthetic Conjugated Estrogens, A.
synthetic conjugated estrogens, B
Choline magnesium trisalicylate may increase the thrombogenic activities of Synthetic Conjugated Estrogens, B.
Tacrolimus
Choline magnesium trisalicylate may increase the nephrotoxic activities of Tacrolimus.
Tafluprost
The therapeutic efficacy of Tafluprost can be decreased when used in combination with Choline magnesium trisalicylate.
Talinolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Talinolol.
Talniflumate
The risk or severity of adverse effects can be increased when Talniflumate is combined with Choline magnesium trisalicylate.
Technetium Tc 99m Medronate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Technetium Tc-99m medronate.
Telmisartan
The risk or severity of adverse effects can be increased when Telmisartan is combined with Choline magnesium trisalicylate.
Temafloxacin
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Temafloxacin.
Tenofovir Disoproxil
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Tenofovir disoproxil.
Tenoxicam
The risk or severity of adverse effects can be increased when Tenoxicam is combined with Choline magnesium trisalicylate.
Terbutaline
Choline magnesium trisalicylate may decrease the antihypertensive activities of Terbutaline.
Terbutaline Sulfate
Choline magnesium trisalicylate may decrease the antihypertensive activities of Terbutaline.
Teriflunomide
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Choline magnesium trisalicylate.
Tertatolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Tertatolol.
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Tiaprofenic acid.
Tibolone
Choline magnesium trisalicylate may increase the thrombogenic activities of Tibolone.
Tiludronate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Tiludronic acid.
Tiludronic Acid
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Tiludronic acid.
Timolol
Choline magnesium trisalicylate may decrease the antihypertensive activities of Timolol.
Timolol Anhydrous
Choline magnesium trisalicylate may decrease the antihypertensive activities of Timolol.
Tixocortol
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Tixocortol.
Tobramycin
Choline magnesium trisalicylate may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Choline magnesium trisalicylate.
Tolmetin
The risk or severity of adverse effects can be increased when Tolmetin is combined with Choline magnesium trisalicylate.
Torsemide
The therapeutic efficacy of Torasemide can be decreased when used in combination with Choline magnesium trisalicylate.
Trandolapril
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Trandolapril.
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Choline magnesium trisalicylate.
Travoprost
The therapeutic efficacy of Travoprost can be decreased when used in combination with Choline magnesium trisalicylate.
Treprostinil
The risk or severity of adverse effects can be increased when Treprostinil is combined with Choline magnesium trisalicylate.
Triamcinolone
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Triamcinolone.
Triamterene
Choline magnesium trisalicylate may decrease the antihypertensive activities of Triamterene.
Tribenoside
The risk or severity of adverse effects can be increased when Tribenoside is combined with Choline magnesium trisalicylate.
Trichlormethiazide
The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Choline magnesium trisalicylate.
Trisodium Citrate Anhydrous
Choline magnesium trisalicylate may increase the anticoagulant activities of Sodium Citrate.
Trolamine Salicylate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Trolamine salicylate.
Trovafloxacin
Choline magnesium trisalicylate may increase the neuroexcitatory activities of Trovafloxacin.
Troxerutin
Choline magnesium trisalicylate may increase the anticoagulant activities of Troxerutin.
UNOPROSTONE
The therapeutic efficacy of Unoprostone can be decreased when used in combination with Choline magnesium trisalicylate.
Valdecoxib
The risk or severity of adverse effects can be increased when Valdecoxib is combined with Choline magnesium trisalicylate.
Valsartan
The risk or severity of adverse effects can be increased when Valsartan is combined with Choline magnesium trisalicylate.
Vancomycin
The serum concentration of Vancomycin can be increased when it is combined with Choline magnesium trisalicylate.
Venlafaxine
Venlafaxine may increase the antiplatelet activities of Choline magnesium trisalicylate.
Warfarin
Choline magnesium trisalicylate may increase the anticoagulant activities of Warfarin.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Choline magnesium trisalicylate.
Zofenopril
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Zofenopril.
Zoledronic Acid
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Zoledronic acid.
Zoledronic Acid Anhydrous
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Zoledronic acid.
Zomepirac
The risk or severity of adverse effects can be increased when Zomepirac is combined with Choline magnesium trisalicylate.
